Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication

The American Journal of Geriatric Pharmacotherapy - Tập 5 - Trang 209-217 - 2007
Brent Forester1,2, Mark Vanelli2,3,4, Joan Hyde5,6, Rosa Perez5,7, Calixte Ahokpossi5,8, William Sribney9, Lesley Adkison1
1McLean Hospital, Belmont, Massachusetts
2Harvard Medical School, Boston, Massachusetts
3Beth Israel Deaconess Hospital, Boston, Massachusetts
4Adheris, Inc., Burlington, Massachusetts
5Hearthstone Alzheimer Care, Ltd., Woburn, Massachusetts
6Current affiliation: Gerontology Institute, University of Massachusetts, Boston, Massachusetts.
7Current affiliation: Center for Aging Studies, University of Maryland, Baltimore, Maryland.
8Boston University, Boston, Massachusetts
9Third Way Statistics, White Lake, New York

Tài liệu tham khảo

Lyketsos, 2000, Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: Initial results from the Depression in Alzheimer's Disease study, Am J Psychiatry, 157, 1686, 10.1176/appi.ajp.157.10.1686 Lyketsos, 2000, Mental and behavioral disturbances in dementia: Findings from the Cache County Study on Memory in Aging, Am J Psychiatry, 157, 708, 10.1176/appi.ajp.157.5.708 Tractenberg, 2002, Estimating the prevalence of agitation and behavioral disturbance in community-dwelling persons with Alzheimer's disease, J Neuropsychiatry Clin Neurosci, 14, 11, 10.1176/appi.neuropsych.14.1.11 Tariot, 2005, Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: A randomized, controlled trial, Am J Geriatr Psychiatry, 13, 942 Profenno, 2004, Pharmacologic management of agitation in Alzheimer's disease, Dement Geriatr Cogn Disord, 17, 65, 10.1159/000074278 Schneider, 2006, Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease, N Engl J Med, 355, 1525, 10.1056/NEJMoa061240 Alexopoulos, 2004, Using antipsychotic agents in older patients, J Clin Psychiatry, 65, 5 Ichikawa, 2005, Valproic acid potentiates both typical and atypical antipsychotic- induced prefrontal cortical dopamine release, Brain Res, 1052, 56, 10.1016/j.brainres.2005.06.009 Sachs, 2002, Combination of a mood stabilizer with risperidone or haloperidol fbr treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety, Am J Psychiatry, 159, 1146, 10.1176/appi.ajp.159.7.1146 Tariot, 2003, Valproate use in neuropsychiatric disorders in the elderly, Psychopharmacol Bull, 37, 116 Porsteinsson, 2001, Placebo- controlled study of divalproex sodium for agitation in dementia, Am J Geriatr Psychiatry, 9, 58, 10.1176/appi.ajgp.9.1.58 Tariot, 2001, Safety and tolerability of divalproex sodium for the treatment of signs and symptoms of mania in elderly patients with dementia: Results of a double-blind, placebo-controlled trial, Curr Ther Res Clin Exp, 62, 51, 10.1016/S0011-393X(01)80042-4 Sival, 2002, Sodium valproate in the treatment of aggressive behavior in patients with dementia—a randomized placebo controlled clinical trial, Int J Geriatr Psychiatry, 17, 579, 10.1002/gps.653